Evidence map›Paper›PMID 27065631›Full record

ArticleTrends in cell & molecular biology

Structural comparison of bacterial multidrug efflux pumps of the major facilitator superfamily.

Indrika Ranaweera, Ugina Shrestha, K C Ranjana, Prathusha Kakarla, T Mark Willmon, Alberto J Hernandez, Mun Mun Mukherjee, Sharla R Barr, Manuel F Varela

Open access · greenAbstract read
In one paragraph

Article in Trends in cell & molecular biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Recent Advances in the Siderophore Biology ofFrontiers in microbiology · 2022
    Review
  9. Article
  10. Bacterial Resistance to Antimicrobial Agents.Antibiotics (Basel, Switzerland) · 2021
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Indrika RanaweeraDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Ugina ShresthaDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
K C RanjanaDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Prathusha KakarlaDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
T Mark WillmonDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Alberto J HernandezDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Mun Mun MukherjeeDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Sharla R BarrDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Manuel F VarelaDepartment of Biology, Eastern New Mexico University, Portales, NM 88130, USA.
Eastern New Mexico University · US

Funding

NM-INBRE Sequencing and Bioinformatics CoreP20GM103451 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI Charlotte C. Gard · 2012 to 2026
$61.2M
ZUNI HEALTH INITIATIVE-PILOT STUDYP20RR016480 · NCRR · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI ZHANG, PENG F · 2001 to 2011
$33.7M
NCRR NIH HHS P20 RR016480NIGMS NIH HHS P20 GM103451
6 · The paper itself

Abstract

The biological membrane is an efficient barrier against water-soluble substances. Solute transporters circumvent this membrane barrier by transporting water-soluble solutes across the membrane to the other sides. These transport proteins are thus required for all living organisms. Microorganisms, such as bacteria, effectively exploit solute transporters to acquire useful nutrients for growth or to expel substances that are inhibitory to their growth. Overall, there are distinct types of related solute transporters that are grouped into families or superfamilies. Of these various transporters, the major facilitator superfamily (MFS) represents a very large and constantly growing group and are driven by solute- and ion-gradients, making them passive and secondary active transporters, respectively. Members of the major facilitator superfamily transport an extreme variety of structurally different substrates such as antimicrobial agents, amino acids, sugars, intermediary metabolites, ions, and other small molecules. Importantly, bacteria, especially pathogenic ones, have evolved multidrug efflux pumps which belong to the major facilitator superfamily. Furthermore, members of this important superfamily share similar primary sequences in the form of highly conserved sequence motifs that confer useful functional properties during transport. The transporters of the superfamily also share similarities in secondary structures, such as possessing 12- or 14-membrane spanning α-helices and the more recently described 3-helix structure repeat element, known as the MFS fold. The three-dimensional structures of bacterial multidrug efflux pumps have been determined for only a few members of the superfamily, all drug pumps of which are surprisingly from

Indexed as

antimicrobial resistancebacteriamajor facilitator superfamilymultidrug efflux

Identifiers

PMID27065631
PMCPMC4822553
OpenAlexW2396341490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.